Factor/effect | Estimate | SE | Odds ratio (OR) estimate | OR 95% CI | P valuec | |
---|---|---|---|---|---|---|
Lower | Upper | |||||
Primary efficacy analysis for IRP A | ||||||
IRP A*Treatment Interactiona | − 0.31 | 0.303 | 0.731 | 0.403 | 1.324 | 0.30 |
IRP A+: DrotAA versus NonDrotAA | 0.11 | 0.245 | 1.112 | 0.688 | 1.799 | 0.66 |
IRP A−: DrotAA versus NonDrotAA | 0.42 | 0.145 | 1.522 | 1.145 | 2.024 | < 0.01 |
DrotAA: IRP A+ versus IRP A− | − 0.30 | 0.258 | 0.740 | 0.446 | 1.228 | 0.24 |
NonDrotAA: IRP A+ versus IRP A− | 0.01 | 0.150 | 1.013 | 0.755 | 1.359 | 0.93 |
AIM Panel PCsb | 0.14 | |||||
Primary efficacy Analysis for IRP B | ||||||
IRP B*Treatment Interactiona | − 0.09 | 0.325 | 0.912 | 0.482 | 1.722 | 0.78 |
IRP B+: DrotAA versus NonDrotAA | 0.23 | 0.277 | 1.257 | 0.730 | 2.162 | 0.41 |
IRP B−: DrotAA versus NonDrotAA | 0.32 | 0.138 | 1.379 | 1.052 | 1.807 | 0.02 |
DrotAA: IRP B+ versus IRP B− | − 0.19 | 0.285 | 0.829 | 0.475 | 1.449 | 0.51 |
NonDrotAA: IRP B+ versus IRP B− | − 0.09 | 0.156 | 0.910 | 0.670 | 1.236 | 0.55 |
AIM Panel PCsb | 0.14 |